한글목차

개요

호르몬 대체요법 시장은 2023-2028년 84억 4,000만 달러로 예측되며, 예측 기간 동안 6.67%의 CAGR로 성장할 것으로 예상됩니다.

본 보고서는 호르몬 대체요법 시장에 대한 전반적인 분석, 시장 규모와 예측, 동향, 성장 촉진요인, 과제, 약 25개 벤더를 포함한 벤더 분석 등의 정보를 전해드립니다.

현재 시장 시나리오, 최신 동향 및 촉진요인, 전체 시장 환경에 대한 최신 분석을 제공합니다. 시장은 혁신적인 호르몬 대체요법 제품의 개발, 호르몬 장애의 유병률 증가, 전 세계 의료 지출 증가 등에 의해 주도되고 있습니다.

이 보고서는 향후 몇 년 동안 호르몬 대체요법 시장의 성장을 견인할 주요 요인 중 하나로 호르몬 대체요법의 적용 확대를 꼽고 있습니다. 또한, 갱년기에 대한 문화적 인식의 변화와 예방적 건강관리에 대한 관심의 증가도 시장 수요를 견인할 것으로 예상됩니다.

목차

제1장 주요 요약

• 시장 개요

제2장 시장 상황

• 시장 생태계

제3장 시장 규모

• 시장 정의
• 시장 부문 분석
• 시장 규모 2023
• 시장 전망 2023-2028

제4장 시장 규모 실적

• 호르몬 대체요법 세계 시장 2018-2022
• 유통 채널별 부문 분석 2018-2022
• 유형별 부문 분석 2018-2022
• 지역별 부문 분석 2018-2022
• 국가별 부문 분석 2018-2022

제5장 Five Forces 분석

• Five Forces 요약
• 구매자의 교섭력
• 공급 기업의 교섭력
• 신규 참여업체의 위협
• 대체품의 위협
• 경쟁의 위협
• 시장 상황

제6장 시장 세분화 : 유통 채널별

• 시장 부문
• 비교 : 유통 채널별
• 병원 약국 : 시장 규모와 예측 2023-2028
• 소매 약국 : 시장 규모와 예측 2023-2028
• 온라인 약국 : 시장 규모와 예측 2023-2028
• 시장 기회 : 유통 채널별

제7장 시장 세분화 : 유형별

• 시장 부문
• 비교 : 유형별
• 에스트로겐과 프로게스테론 대체요법 : 시장 규모와 예측 2023-2028
• 갑상선 호르몬 대체요법 : 시장 규모와 예측 2023-2028
• HGH 대체요법 : 시장 규모와 예측 2023-2028
• 기타 : 시장 규모와 예측 2023-2028
• 시장 기회 : 유형별

제8장 고객 상황

• 고객 상황 개요

제9장 지역별 상황

• 지역별 세분화
• 지역별 비교
• 북미 : 시장 규모와 예측 2023-2028
• 유럽 : 시장 규모와 예측 2023-2028
• 아시아 : 시장 규모와 예측 2023-2028
• 세계 기타 지역 : 시장 규모와 예측 2023-2028
• 미국 : 시장 규모와 예측 2023-2028
• 독일 : 시장 규모와 예측 2023-2028
• 중국 : 시장 규모와 예측 2023-2028
• 영국 : 시장 규모와 예측 2023-2028
• 일본 : 시장 규모와 예측 2023-2028
• 시장 기회 : 지역 상황별

제10장 촉진요인, 과제 및 동향

• 시장 성장 촉진요인
• 시장 과제
• 성장 촉진요인과 과제의 영향
• 시장 동향

제11장 벤더 상황

• 개요
• 벤더 상황
• 혼란 상황
• 업계 리스크

제12장 벤더 분석

• 대상 벤더
• 벤더의 시장 포지셔닝
• Abbott Laboratories
• AbbVie Inc.
• Amgen Inc.
• Bayer AG
• Besins Healthcare Monaco
• Eli Lilly and Co.
• Endo International Plc
• F. Hoffmann La Roche Ltd.
• Merck KGaA
• Mithra Pharmaceuticals SA
• Novartis AG
• Novo Nordisk AS
• Pfizer Inc.
• Teva Pharmaceutical Industries Ltd.
• Viatris Inc.

제13장 부록

영문목차

Abstract

The hormone replacement therapy market is forecasted to grow by USD 8.44 bn during 2023-2028, accelerating at a CAGR of 6.67% during the forecast period. The report on the hormone replacement therapy market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by development of innovative hormone replacement therapy products, increasing prevalence of hormonal disorders, and growing global healthcare expenditure.

Technavio's hormone replacement therapy market is segmented as below:

By Distribution Channel

• Hospital pharmacies
• Retail pharmacies
• Online pharmacies

By Type

• Estrogen and progesterone replacement therapy
• Thyroid hormone replacement therapy
• HGH replacement therapy
• Others

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the expanding applications of hormone replacement therapy as one of the prime reasons driving the hormone replacement therapy market growth during the next few years. Also, cultural shifts in attitudes toward menopause and rising focus on preventive healthcare will lead to sizable demand in the market.

The report on the hormone replacement therapy market covers the following areas:

• Hormone replacement therapy market sizing
• Hormone replacement therapy market forecast
• Hormone replacement therapy market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading hormone replacement therapy market vendors that include Abbott Laboratories, AbbVie Inc., Amgen Inc., Bayer AG, Besins Healthcare Monaco, Eli Lilly and Co., Endo International Plc, F. Hoffmann La Roche Ltd., Hisamitsu Pharmaceutical Co. Inc., Lupin Ltd., Merck KGaA, Mithra Pharmaceuticals SA, Novartis AG, Novo Nordisk AS, Pfizer Inc., Teva Pharmaceutical Industries Ltd., and Viatris Inc.. Also, the hormone replacement therapy market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary - Chart on Market Overview
• Exhibit 02: Executive Summary - Data Table on Market Overview
• Exhibit 03: Executive Summary - Chart on Global Market Characteristics
• Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
• Exhibit 05: Executive Summary - Chart on Market Segmentation by Distribution Channel
• Exhibit 06: Executive Summary - Chart on Market Segmentation by Type
• Exhibit 07: Executive Summary - Chart on Incremental Growth
• Exhibit 08: Executive Summary - Data Table on Incremental Growth
• Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 12: Offerings of vendors included in the market definition
• 3.2 Market segment analysis
• Exhibit 13: Market segments
• 3.3 Market size 2023
• 3.4 Market outlook: Forecast for 2023-2028
• Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
• Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

• 4.1 Global hormone replacement therapy market 2018 - 2022
• Exhibit 18: Historic Market Size - Data Table on global hormone replacement therapy market 2018 - 2022 ($ billion)
• 4.2 Distribution Channel Segment Analysis 2018 - 2022
• Exhibit 19: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ billion)
• 4.3 Type Segment Analysis 2018 - 2022
• Exhibit 20: Historic Market Size - Type Segment 2018 - 2022 ($ billion)
• 4.4 Geography Segment Analysis 2018 - 2022
• Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
• 4.5 Country Segment Analysis 2018 - 2022
• Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)

5 Five Forces Analysis

• 5.1 Five forces summary
• Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
• 5.2 Bargaining power of buyers
• Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
• 5.3 Bargaining power of suppliers
• Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• 5.4 Threat of new entrants
• Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
• 5.5 Threat of substitutes
• Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
• 5.6 Threat of rivalry
• Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
• 5.7 Market condition
• Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Distribution Channel

• 6.1 Market segments
• Exhibit 30: Chart on Distribution Channel - Market share 2023-2028 (%)
• Exhibit 31: Data Table on Distribution Channel - Market share 2023-2028 (%)
• 6.2 Comparison by Distribution Channel
• Exhibit 32: Chart on Comparison by Distribution Channel
• Exhibit 33: Data Table on Comparison by Distribution Channel
• 6.3 Hospital pharmacies - Market size and forecast 2023-2028
• Exhibit 34: Chart on Hospital pharmacies - Market size and forecast 2023-2028 ($ billion)
• Exhibit 35: Data Table on Hospital pharmacies - Market size and forecast 2023-2028 ($ billion)
• Exhibit 36: Chart on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
• Exhibit 37: Data Table on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
• 6.4 Retail pharmacies - Market size and forecast 2023-2028
• Exhibit 38: Chart on Retail pharmacies - Market size and forecast 2023-2028 ($ billion)
• Exhibit 39: Data Table on Retail pharmacies - Market size and forecast 2023-2028 ($ billion)
• Exhibit 40: Chart on Retail pharmacies - Year-over-year growth 2023-2028 (%)
• Exhibit 41: Data Table on Retail pharmacies - Year-over-year growth 2023-2028 (%)
• 6.5 Online pharmacies - Market size and forecast 2023-2028
• Exhibit 42: Chart on Online pharmacies - Market size and forecast 2023-2028 ($ billion)
• Exhibit 43: Data Table on Online pharmacies - Market size and forecast 2023-2028 ($ billion)
• Exhibit 44: Chart on Online pharmacies - Year-over-year growth 2023-2028 (%)
• Exhibit 45: Data Table on Online pharmacies - Year-over-year growth 2023-2028 (%)
• 6.6 Market opportunity by Distribution Channel
• Exhibit 46: Market opportunity by Distribution Channel ($ billion)
• Exhibit 47: Data Table on Market opportunity by Distribution Channel ($ billion)

7 Market Segmentation by Type

• 7.1 Market segments
• Exhibit 48: Chart on Type - Market share 2023-2028 (%)
• Exhibit 49: Data Table on Type - Market share 2023-2028 (%)
• 7.2 Comparison by Type
• Exhibit 50: Chart on Comparison by Type
• Exhibit 51: Data Table on Comparison by Type
• 7.3 Estrogen and progesterone replacement therapy - Market size and forecast 2023-2028
• Exhibit 52: Chart on Estrogen and progesterone replacement therapy - Market size and forecast 2023-2028 ($ billion)
• Exhibit 53: Data Table on Estrogen and progesterone replacement therapy - Market size and forecast 2023-2028 ($ billion)
• Exhibit 54: Chart on Estrogen and progesterone replacement therapy - Year-over-year growth 2023-2028 (%)
• Exhibit 55: Data Table on Estrogen and progesterone replacement therapy - Year-over-year growth 2023-2028 (%)
• 7.4 Thyroid hormone replacement therapy - Market size and forecast 2023-2028
• Exhibit 56: Chart on Thyroid hormone replacement therapy - Market size and forecast 2023-2028 ($ billion)
• Exhibit 57: Data Table on Thyroid hormone replacement therapy - Market size and forecast 2023-2028 ($ billion)
• Exhibit 58: Chart on Thyroid hormone replacement therapy - Year-over-year growth 2023-2028 (%)
• Exhibit 59: Data Table on Thyroid hormone replacement therapy - Year-over-year growth 2023-2028 (%)
• 7.5 HGH replacement therapy - Market size and forecast 2023-2028
• Exhibit 60: Chart on HGH replacement therapy - Market size and forecast 2023-2028 ($ billion)
• Exhibit 61: Data Table on HGH replacement therapy - Market size and forecast 2023-2028 ($ billion)
• Exhibit 62: Chart on HGH replacement therapy - Year-over-year growth 2023-2028 (%)
• Exhibit 63: Data Table on HGH replacement therapy - Year-over-year growth 2023-2028 (%)
• 7.6 Others - Market size and forecast 2023-2028
• Exhibit 64: Chart on Others - Market size and forecast 2023-2028 ($ billion)
• Exhibit 65: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
• Exhibit 66: Chart on Others - Year-over-year growth 2023-2028 (%)
• Exhibit 67: Data Table on Others - Year-over-year growth 2023-2028 (%)
• 7.7 Market opportunity by Type
• Exhibit 68: Market opportunity by Type ($ billion)
• Exhibit 69: Data Table on Market opportunity by Type ($ billion)

8 Customer Landscape

• 8.1 Customer landscape overview
• Exhibit 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
• Exhibit 71: Chart on Market share By Geographical Landscape 2023-2028 (%)
• Exhibit 72: Data Table on Market share By Geographical Landscape 2023-2028 (%)
• 9.2 Geographic comparison
• Exhibit 73: Chart on Geographic comparison
• Exhibit 74: Data Table on Geographic comparison
• 9.3 North America - Market size and forecast 2023-2028
• Exhibit 75: Chart on North America - Market size and forecast 2023-2028 ($ billion)
• Exhibit 76: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
• Exhibit 77: Chart on North America - Year-over-year growth 2023-2028 (%)
• Exhibit 78: Data Table on North America - Year-over-year growth 2023-2028 (%)
• 9.4 Europe - Market size and forecast 2023-2028
• Exhibit 79: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
• Exhibit 80: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
• Exhibit 81: Chart on Europe - Year-over-year growth 2023-2028 (%)
• Exhibit 82: Data Table on Europe - Year-over-year growth 2023-2028 (%)
• 9.5 Asia - Market size and forecast 2023-2028
• Exhibit 83: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
• Exhibit 84: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
• Exhibit 85: Chart on Asia - Year-over-year growth 2023-2028 (%)
• Exhibit 86: Data Table on Asia - Year-over-year growth 2023-2028 (%)
• 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
• Exhibit 87: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
• Exhibit 88: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
• Exhibit 89: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibit 90: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• 9.7 US - Market size and forecast 2023-2028
• Exhibit 91: Chart on US - Market size and forecast 2023-2028 ($ billion)
• Exhibit 92: Data Table on US - Market size and forecast 2023-2028 ($ billion)
• Exhibit 93: Chart on US - Year-over-year growth 2023-2028 (%)
• Exhibit 94: Data Table on US - Year-over-year growth 2023-2028 (%)
• 9.8 Germany - Market size and forecast 2023-2028
• Exhibit 95: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
• Exhibit 96: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
• Exhibit 97: Chart on Germany - Year-over-year growth 2023-2028 (%)
• Exhibit 98: Data Table on Germany - Year-over-year growth 2023-2028 (%)
• 9.9 China - Market size and forecast 2023-2028
• Exhibit 99: Chart on China - Market size and forecast 2023-2028 ($ billion)
• Exhibit 100: Data Table on China - Market size and forecast 2023-2028 ($ billion)
• Exhibit 101: Chart on China - Year-over-year growth 2023-2028 (%)
• Exhibit 102: Data Table on China - Year-over-year growth 2023-2028 (%)
• 9.10 UK - Market size and forecast 2023-2028
• Exhibit 103: Chart on UK - Market size and forecast 2023-2028 ($ billion)
• Exhibit 104: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
• Exhibit 105: Chart on UK - Year-over-year growth 2023-2028 (%)
• Exhibit 106: Data Table on UK - Year-over-year growth 2023-2028 (%)
• 9.11 Japan - Market size and forecast 2023-2028
• Exhibit 107: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
• Exhibit 108: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
• Exhibit 109: Chart on Japan - Year-over-year growth 2023-2028 (%)
• Exhibit 110: Data Table on Japan - Year-over-year growth 2023-2028 (%)
• 9.12 Market opportunity By Geographical Landscape
• Exhibit 111: Market opportunity By Geographical Landscape ($ billion)
• Exhibit 112: Data Tables on Market opportunity By Geographical Landscape ($ billion)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
• Exhibit 113: Impact of drivers and challenges in 2023 and 2028
• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview
• 11.2 Vendor landscape
• Exhibit 114: Overview on Criticality of inputs and Factors of differentiation
• 11.3 Landscape disruption
• Exhibit 115: Overview on factors of disruption
• 11.4 Industry risks
• Exhibit 116: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered
• Exhibit 117: Vendors covered
• 12.2 Market positioning of vendors
• Exhibit 118: Matrix on vendor position and classification
• 12.3 Abbott Laboratories
• Exhibit 119: Abbott Laboratories - Overview
• Exhibit 120: Abbott Laboratories - Business segments
• Exhibit 121: Abbott Laboratories - Key news
• Exhibit 122: Abbott Laboratories - Key offerings
• Exhibit 123: Abbott Laboratories - Segment focus
• 12.4 AbbVie Inc.
• Exhibit 124: AbbVie Inc. - Overview
• Exhibit 125: AbbVie Inc. - Product / Service
• Exhibit 126: AbbVie Inc. - Key news
• Exhibit 127: AbbVie Inc. - Key offerings
• 12.5 Amgen Inc.
• Exhibit 128: Amgen Inc. - Overview
• Exhibit 129: Amgen Inc. - Product / Service
• Exhibit 130: Amgen Inc. - Key offerings
• 12.6 Bayer AG
• Exhibit 131: Bayer AG - Overview
• Exhibit 132: Bayer AG - Business segments
• Exhibit 133: Bayer AG - Key news
• Exhibit 134: Bayer AG - Key offerings
• Exhibit 135: Bayer AG - Segment focus
• 12.7 Besins Healthcare Monaco
• Exhibit 136: Besins Healthcare Monaco - Overview
• Exhibit 137: Besins Healthcare Monaco - Product / Service
• Exhibit 138: Besins Healthcare Monaco - Key offerings
• 12.8 Eli Lilly and Co.
• Exhibit 139: Eli Lilly and Co. - Overview
• Exhibit 140: Eli Lilly and Co. - Product / Service
• Exhibit 141: Eli Lilly and Co. - Key news
• Exhibit 142: Eli Lilly and Co. - Key offerings
• 12.9 Endo International Plc
• Exhibit 143: Endo International Plc - Overview
• Exhibit 144: Endo International Plc - Business segments
• Exhibit 145: Endo International Plc - Key news
• Exhibit 146: Endo International Plc - Key offerings
• Exhibit 147: Endo International Plc - Segment focus
• 12.10 F. Hoffmann La Roche Ltd.
• Exhibit 148: F. Hoffmann La Roche Ltd. - Overview
• Exhibit 149: F. Hoffmann La Roche Ltd. - Business segments
• Exhibit 150: F. Hoffmann La Roche Ltd. - Key news
• Exhibit 151: F. Hoffmann La Roche Ltd. - Key offerings
• Exhibit 152: F. Hoffmann La Roche Ltd. - Segment focus
• 12.11 Merck KGaA
• Exhibit 153: Merck KGaA - Overview
• Exhibit 154: Merck KGaA - Business segments
• Exhibit 155: Merck KGaA - Key news
• Exhibit 156: Merck KGaA - Key offerings
• Exhibit 157: Merck KGaA - Segment focus
• 12.12 Mithra Pharmaceuticals SA
• Exhibit 158: Mithra Pharmaceuticals SA - Overview
• Exhibit 159: Mithra Pharmaceuticals SA - Product / Service
• Exhibit 160: Mithra Pharmaceuticals SA - Key offerings
• 12.13 Novartis AG
• Exhibit 161: Novartis AG - Overview
• Exhibit 162: Novartis AG - Business segments
• Exhibit 163: Novartis AG - Key offerings
• Exhibit 164: Novartis AG - Segment focus
• 12.14 Novo Nordisk AS
• Exhibit 165: Novo Nordisk AS - Overview
• Exhibit 166: Novo Nordisk AS - Business segments
• Exhibit 167: Novo Nordisk AS - Key offerings
• Exhibit 168: Novo Nordisk AS - Segment focus
• 12.15 Pfizer Inc.
• Exhibit 169: Pfizer Inc. - Overview
• Exhibit 170: Pfizer Inc. - Product / Service
• Exhibit 171: Pfizer Inc. - Key news
• Exhibit 172: Pfizer Inc. - Key offerings
• 12.16 Teva Pharmaceutical Industries Ltd.
• Exhibit 173: Teva Pharmaceutical Industries Ltd. - Overview
• Exhibit 174: Teva Pharmaceutical Industries Ltd. - Business segments
• Exhibit 175: Teva Pharmaceutical Industries Ltd. - Key news
• Exhibit 176: Teva Pharmaceutical Industries Ltd. - Key offerings
• Exhibit 177: Teva Pharmaceutical Industries Ltd. - Segment focus
• 12.17 Viatris Inc.
• Exhibit 178: Viatris Inc. - Overview
• Exhibit 179: Viatris Inc. - Business segments
• Exhibit 180: Viatris Inc. - Key news
• Exhibit 181: Viatris Inc. - Key offerings
• Exhibit 182: Viatris Inc. - Segment focus

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
• Exhibit 183: Inclusions checklist
• Exhibit 184: Exclusions checklist
• 13.3 Currency conversion rates for US$
• Exhibit 185: Currency conversion rates for US$
• 13.4 Research methodology
• Exhibit 186: Research methodology
• Exhibit 187: Validation techniques employed for market sizing
• Exhibit 188: Information sources
• 13.5 List of abbreviations
• Exhibit 189: List of abbreviations